ATE468846T1 - Magenresistente pharmazeutische dosierform mit n- (2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d- glutaminsäure (lk-423) - Google Patents

Magenresistente pharmazeutische dosierform mit n- (2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d- glutaminsäure (lk-423)

Info

Publication number
ATE468846T1
ATE468846T1 AT05733297T AT05733297T ATE468846T1 AT E468846 T1 ATE468846 T1 AT E468846T1 AT 05733297 T AT05733297 T AT 05733297T AT 05733297 T AT05733297 T AT 05733297T AT E468846 T1 ATE468846 T1 AT E468846T1
Authority
AT
Austria
Prior art keywords
phthalimidoethoxy
alanyl
acetyl
dosage form
pharmaceutical dosage
Prior art date
Application number
AT05733297T
Other languages
English (en)
Inventor
Marija Bogataj
Ales Mrhar
Anton Lavric
Manica Cerne
Doris Tibaut
Anton Stalc
Uros Urleb
Tatjana Mateovic
Greta Cof
Janez Kerk
Rok Dreu
Fumio Yoneda
Shizuko Muraoka
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Application granted granted Critical
Publication of ATE468846T1 publication Critical patent/ATE468846T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05733297T 2004-03-26 2005-03-24 Magenresistente pharmazeutische dosierform mit n- (2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d- glutaminsäure (lk-423) ATE468846T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200400094 2004-03-26
PCT/EP2005/003175 WO2005092295A1 (en) 2004-03-26 2005-03-24 Gastroresistant pharmaceutical dosage form comprising n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423)

Publications (1)

Publication Number Publication Date
ATE468846T1 true ATE468846T1 (de) 2010-06-15

Family

ID=34964906

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05733297T ATE468846T1 (de) 2004-03-26 2005-03-24 Magenresistente pharmazeutische dosierform mit n- (2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d- glutaminsäure (lk-423)

Country Status (15)

Country Link
US (1) US20100183714A1 (de)
EP (1) EP1734933B1 (de)
JP (1) JP2007530492A (de)
CN (1) CN1956707B (de)
AR (1) AR048342A1 (de)
AT (1) ATE468846T1 (de)
AU (1) AU2005226927B2 (de)
BR (1) BRPI0509271A (de)
CA (1) CA2559685A1 (de)
DE (1) DE602005021475D1 (de)
MY (1) MY145329A (de)
PE (1) PE20051163A1 (de)
RU (1) RU2375047C2 (de)
TW (1) TW200600121A (de)
WO (1) WO2005092295A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2678131A1 (en) * 2006-11-17 2008-05-22 Antoine Andremont Colonic delivery using zn/pectin beads with a eudragit coating.
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
WO2009037264A2 (en) * 2007-09-17 2009-03-26 Da Volterra Colonic delivery of antimicrobial agents
SI3121280T1 (sl) 2008-11-13 2025-08-29 Nogra Pharma Limited Antismiselne sestave in postopki za njihovo izdelavo ter uporabo
MX391477B (es) * 2015-06-01 2025-03-19 Xeno Biosciences Inc Metodos y composiciones para modular la microbiota intestinal y para manejar el peso
WO2017223337A1 (en) * 2016-06-23 2017-12-28 Nutrivert Llc Methods to promote growth and improve feed conversion in animals
CN110520534A (zh) * 2016-11-09 2019-11-29 恩根尼公司 程序性死亡配体1的肠表达
KR102616436B1 (ko) * 2016-12-14 2023-12-27 비오라 쎄라퓨틱스, 인크. Tnf 저해제로의 위장관 질환의 치료
AU2017378398B2 (en) * 2016-12-14 2023-02-02 Bt Bidco, Inc. Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices
CA3045931A1 (en) * 2016-12-14 2018-06-21 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an integrin inhibitor
CN108968074B (zh) * 2018-06-06 2021-09-28 福建省农业科学院农业工程技术研究所 一种结肠靶向递送的银耳糖醛酸多糖-芙蓉李花青素复合物及其制备方法
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법
BR112022019202A2 (pt) 2020-03-26 2022-11-08 Nutrivert Llc Oligopeptídeo, composição farmacêutica, composição, e, método para reduzir a inflamação intestinal em um ser humano, para promover crescimento em um animal e para realçar conversão de alimento em um animal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU660147B2 (en) * 1990-05-04 1995-06-15 Perio Products Ltd. Colonic drug delivery system
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
YU183090A (sh) * 1990-09-27 1992-12-21 Lek Novi n-acildipeptidi, postopki za njihovo pripravo in farmacevtski pripravki, kojih vsebujejo
DE19732903A1 (de) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems

Also Published As

Publication number Publication date
JP2007530492A (ja) 2007-11-01
MY145329A (en) 2012-01-31
CN1956707A (zh) 2007-05-02
DE602005021475D1 (de) 2010-07-08
AU2005226927B2 (en) 2010-09-23
CN1956707B (zh) 2010-12-29
PE20051163A1 (es) 2006-02-21
EP1734933B1 (de) 2010-05-26
EP1734933A1 (de) 2006-12-27
RU2006137660A (ru) 2008-05-10
US20100183714A1 (en) 2010-07-22
AU2005226927A1 (en) 2005-10-06
AR048342A1 (es) 2006-04-19
CA2559685A1 (en) 2005-10-06
BRPI0509271A (pt) 2007-09-04
WO2005092295A1 (en) 2005-10-06
TW200600121A (en) 2006-01-01
RU2375047C2 (ru) 2009-12-10

Similar Documents

Publication Publication Date Title
ATE403432T1 (de) Pharmazeutische darreichungsform mit gesteuerter freigabe eines cholesterylester- transferproteininhibitors
ATE458486T1 (de) Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung
DE60332393D1 (de) Flüssige pharmazeutische zusammensetzung mit pyridonderivaten
DE60308372D1 (de) Dosierungsverabreichungsvorrichtung
EP1786359A4 (de) Medizinische vorrichtung zur abgabe biologisch aktiven materials
EP1477403A4 (de) Arzneimittelversorgung
DE60316323D1 (de) Feste pharmazeutische formulierungen mit telmisartan
ATE489953T1 (de) Manipulationssichere orale pharmazeutische dosierformen enthaltend ein opiatanalgetikum
DK1545662T3 (da) Lægemiddelindgivelsessystem
DE602005012107D1 (de) Pharmazeutische formulierungen mit einem antibioti
ATE468846T1 (de) Magenresistente pharmazeutische dosierform mit n- (2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d- glutaminsäure (lk-423)
ATE415949T1 (de) Pharmazeutische formulierung mit levothyroxin- natrium
ATE507831T1 (de) Melatonin enthaltende pharmazeutische formulierung
DE60310526D1 (de) Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion
DE60306747D1 (de) Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion
DK1694295T3 (da) Farmaceutisk oral doseringsform omfattende et ikke-steroidt antiinflammatorisk lægemiddel med god palatabilitet
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar
DK1750765T3 (da) Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel
ATE439354T1 (de) Pharmazeutische salze von reboxetin
DE112004001747D2 (de) Pharmazeutischer Wirkstoff gegen Magengeschwüre
UA9011S (uk) Упаковка фармацевтичного засобу «кетозорал»
ATA14072002A (de) Pharmazeutische zubereitung von diclofenac-natrium
UA8582S (uk) Ємність-туба для фармацевтичного засобу
SE0200008D0 (sv) New pharmaceutically compounds
UA10726S (uk) Комплект упаковок для фармацевтичного препарату «дермазол»

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1734933

Country of ref document: EP